nodes	percent_of_prediction	percent_of_DWPC	metapath
Vildagliptin—Localized exfoliation—Bleomycin—melanoma	0.0804	0.0804	CcSEcCtD
Vildagliptin—Skin exfoliation—Bleomycin—melanoma	0.0207	0.0207	CcSEcCtD
Vildagliptin—Infestation NOS—Vemurafenib—melanoma	0.02	0.02	CcSEcCtD
Vildagliptin—Infestation—Vemurafenib—melanoma	0.02	0.02	CcSEcCtD
Vildagliptin—Skin exfoliation—Carmustine—melanoma	0.018	0.018	CcSEcCtD
Vildagliptin—Oedema peripheral—Vemurafenib—melanoma	0.0177	0.0177	CcSEcCtD
Vildagliptin—Connective tissue disorder—Vemurafenib—melanoma	0.0176	0.0176	CcSEcCtD
Vildagliptin—Skin exfoliation—Temozolomide—melanoma	0.0174	0.0174	CcSEcCtD
Vildagliptin—Angiopathy—Vemurafenib—melanoma	0.0163	0.0163	CcSEcCtD
Vildagliptin—Chills—Vemurafenib—melanoma	0.0161	0.0161	CcSEcCtD
Vildagliptin—Malnutrition—Vemurafenib—melanoma	0.0156	0.0156	CcSEcCtD
Vildagliptin—Liver function test abnormal—Dactinomycin—melanoma	0.0135	0.0135	CcSEcCtD
Vildagliptin—Arthralgia—Vemurafenib—melanoma	0.0133	0.0133	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.0132	0.0132	CcSEcCtD
Vildagliptin—Infection—Vemurafenib—melanoma	0.0127	0.0127	CcSEcCtD
Vildagliptin—Liver function test abnormal—Carmustine—melanoma	0.0127	0.0127	CcSEcCtD
Vildagliptin—Nervous system disorder—Vemurafenib—melanoma	0.0125	0.0125	CcSEcCtD
Vildagliptin—Skin disorder—Vemurafenib—melanoma	0.0124	0.0124	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Vemurafenib—melanoma	0.0116	0.0116	CcSEcCtD
Vildagliptin—Skin exfoliation—Docetaxel—melanoma	0.0116	0.0116	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Vemurafenib—melanoma	0.011	0.011	CcSEcCtD
Vildagliptin—Fatigue—Vemurafenib—melanoma	0.011	0.011	CcSEcCtD
Vildagliptin—Constipation—Vemurafenib—melanoma	0.0109	0.0109	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Temozolomide—melanoma	0.0107	0.0107	CcSEcCtD
Vildagliptin—Weight increased—Temozolomide—melanoma	0.0104	0.0104	CcSEcCtD
Vildagliptin—Infestation—Temozolomide—melanoma	0.0102	0.0102	CcSEcCtD
Vildagliptin—Infestation NOS—Temozolomide—melanoma	0.0102	0.0102	CcSEcCtD
Vildagliptin—Hepatitis—Dactinomycin—melanoma	0.0101	0.0101	CcSEcCtD
Vildagliptin—Chills—Bleomycin—melanoma	0.00976	0.00976	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Temozolomide—melanoma	0.00966	0.00966	CcSEcCtD
Vildagliptin—Oedema peripheral—Carmustine—melanoma	0.00935	0.00935	CcSEcCtD
Vildagliptin—Connective tissue disorder—Carmustine—melanoma	0.00933	0.00933	CcSEcCtD
Vildagliptin—Dermatitis bullous—Docetaxel—melanoma	0.00923	0.00923	CcSEcCtD
Vildagliptin—Hepatitis—Temozolomide—melanoma	0.00917	0.00917	CcSEcCtD
Vildagliptin—Asthenia—Vemurafenib—melanoma	0.00915	0.00915	CcSEcCtD
Vildagliptin—Chills—Dactinomycin—melanoma	0.0091	0.0091	CcSEcCtD
Vildagliptin—Oedema peripheral—Temozolomide—melanoma	0.00904	0.00904	CcSEcCtD
Vildagliptin—Connective tissue disorder—Temozolomide—melanoma	0.00901	0.00901	CcSEcCtD
Vildagliptin—Diarrhoea—Vemurafenib—melanoma	0.00872	0.00872	CcSEcCtD
Vildagliptin—Dizziness—Vemurafenib—melanoma	0.00843	0.00843	CcSEcCtD
Vildagliptin—Angiopathy—Temozolomide—melanoma	0.00832	0.00832	CcSEcCtD
Vildagliptin—Malnutrition—Carmustine—melanoma	0.00826	0.00826	CcSEcCtD
Vildagliptin—Chills—Temozolomide—melanoma	0.00823	0.00823	CcSEcCtD
Vildagliptin—Liver function test abnormal—Docetaxel—melanoma	0.00814	0.00814	CcSEcCtD
Vildagliptin—Headache—Vemurafenib—melanoma	0.00799	0.00799	CcSEcCtD
Vildagliptin—Malnutrition—Temozolomide—melanoma	0.00798	0.00798	CcSEcCtD
Vildagliptin—Nasopharyngitis—Docetaxel—melanoma	0.00788	0.00788	CcSEcCtD
Vildagliptin—Tremor—Carmustine—melanoma	0.00774	0.00774	CcSEcCtD
Vildagliptin—Oedema—Bleomycin—melanoma	0.00773	0.00773	CcSEcCtD
Vildagliptin—Infection—Bleomycin—melanoma	0.00767	0.00767	CcSEcCtD
Vildagliptin—Nausea—Vemurafenib—melanoma	0.00757	0.00757	CcSEcCtD
Vildagliptin—Tremor—Temozolomide—melanoma	0.00748	0.00748	CcSEcCtD
Vildagliptin—Angioedema—Temozolomide—melanoma	0.0073	0.0073	CcSEcCtD
Vildagliptin—Oedema—Dactinomycin—melanoma	0.0072	0.0072	CcSEcCtD
Vildagliptin—Infection—Dactinomycin—melanoma	0.00716	0.00716	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Bleomycin—melanoma	0.00704	0.00704	CcSEcCtD
Vildagliptin—Weight increased—Docetaxel—melanoma	0.00694	0.00694	CcSEcCtD
Vildagliptin—Arthralgia—Temozolomide—melanoma	0.0068	0.0068	CcSEcCtD
Vildagliptin—Infestation NOS—Docetaxel—melanoma	0.00679	0.00679	CcSEcCtD
Vildagliptin—Infestation—Docetaxel—melanoma	0.00679	0.00679	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00675	0.00675	CcSEcCtD
Vildagliptin—Oedema—Carmustine—melanoma	0.00674	0.00674	CcSEcCtD
Vildagliptin—Infection—Carmustine—melanoma	0.0067	0.0067	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00656	0.00656	CcSEcCtD
Vildagliptin—Oedema—Temozolomide—melanoma	0.00652	0.00652	CcSEcCtD
Vildagliptin—Infection—Temozolomide—melanoma	0.00647	0.00647	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Docetaxel—melanoma	0.00643	0.00643	CcSEcCtD
Vildagliptin—Nervous system disorder—Temozolomide—melanoma	0.00639	0.00639	CcSEcCtD
Vildagliptin—Skin disorder—Temozolomide—melanoma	0.00633	0.00633	CcSEcCtD
Vildagliptin—Hyperhidrosis—Temozolomide—melanoma	0.0063	0.0063	CcSEcCtD
Vildagliptin—Fatigue—Dactinomycin—melanoma	0.00621	0.00621	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Carmustine—melanoma	0.00614	0.00614	CcSEcCtD
Vildagliptin—Urticaria—Bleomycin—melanoma	0.00614	0.00614	CcSEcCtD
Vildagliptin—Hepatitis—Docetaxel—melanoma	0.0061	0.0061	CcSEcCtD
Vildagliptin—Oedema peripheral—Docetaxel—melanoma	0.00601	0.00601	CcSEcCtD
Vildagliptin—Connective tissue disorder—Docetaxel—melanoma	0.00599	0.00599	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Temozolomide—melanoma	0.00594	0.00594	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Carmustine—melanoma	0.00582	0.00582	CcSEcCtD
Vildagliptin—Constipation—Carmustine—melanoma	0.00577	0.00577	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Temozolomide—melanoma	0.00563	0.00563	CcSEcCtD
Vildagliptin—Fatigue—Temozolomide—melanoma	0.00562	0.00562	CcSEcCtD
Vildagliptin—Constipation—Temozolomide—melanoma	0.00557	0.00557	CcSEcCtD
Vildagliptin—Asthenia—Bleomycin—melanoma	0.00554	0.00554	CcSEcCtD
Vildagliptin—Angiopathy—Docetaxel—melanoma	0.00553	0.00553	CcSEcCtD
Vildagliptin—Chills—Docetaxel—melanoma	0.00547	0.00547	CcSEcCtD
Vildagliptin—Malnutrition—Docetaxel—melanoma	0.00531	0.00531	CcSEcCtD
Vildagliptin—Urticaria—Temozolomide—melanoma	0.00518	0.00518	CcSEcCtD
Vildagliptin—Asthenia—Dactinomycin—melanoma	0.00517	0.00517	CcSEcCtD
Vildagliptin—Diarrhoea—Dactinomycin—melanoma	0.00493	0.00493	CcSEcCtD
Vildagliptin—Asthenia—Carmustine—melanoma	0.00484	0.00484	CcSEcCtD
Vildagliptin—Asthenia—Temozolomide—melanoma	0.00468	0.00468	CcSEcCtD
Vildagliptin—Diarrhoea—Carmustine—melanoma	0.00461	0.00461	CcSEcCtD
Vildagliptin—Nausea—Bleomycin—melanoma	0.00459	0.00459	CcSEcCtD
Vildagliptin—Arthralgia—Docetaxel—melanoma	0.00452	0.00452	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00449	0.00449	CcSEcCtD
Vildagliptin—Dizziness—Carmustine—melanoma	0.00446	0.00446	CcSEcCtD
Vildagliptin—Diarrhoea—Temozolomide—melanoma	0.00446	0.00446	CcSEcCtD
Vildagliptin—Oedema—Docetaxel—melanoma	0.00433	0.00433	CcSEcCtD
Vildagliptin—Dizziness—Temozolomide—melanoma	0.00431	0.00431	CcSEcCtD
Vildagliptin—Infection—Docetaxel—melanoma	0.00431	0.00431	CcSEcCtD
Vildagliptin—Nausea—Dactinomycin—melanoma	0.00428	0.00428	CcSEcCtD
Vildagliptin—Nervous system disorder—Docetaxel—melanoma	0.00425	0.00425	CcSEcCtD
Vildagliptin—Headache—Carmustine—melanoma	0.00422	0.00422	CcSEcCtD
Vildagliptin—Skin disorder—Docetaxel—melanoma	0.00421	0.00421	CcSEcCtD
Vildagliptin—Headache—Temozolomide—melanoma	0.00408	0.00408	CcSEcCtD
Vildagliptin—Nausea—Carmustine—melanoma	0.00401	0.00401	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Docetaxel—melanoma	0.00395	0.00395	CcSEcCtD
Vildagliptin—Nausea—Temozolomide—melanoma	0.00387	0.00387	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Docetaxel—melanoma	0.00374	0.00374	CcSEcCtD
Vildagliptin—Fatigue—Docetaxel—melanoma	0.00374	0.00374	CcSEcCtD
Vildagliptin—Constipation—Docetaxel—melanoma	0.00371	0.00371	CcSEcCtD
Vildagliptin—Asthenia—Docetaxel—melanoma	0.00311	0.00311	CcSEcCtD
Vildagliptin—Diarrhoea—Docetaxel—melanoma	0.00297	0.00297	CcSEcCtD
Vildagliptin—Dizziness—Docetaxel—melanoma	0.00287	0.00287	CcSEcCtD
Vildagliptin—Headache—Docetaxel—melanoma	0.00271	0.00271	CcSEcCtD
Vildagliptin—Nausea—Docetaxel—melanoma	0.00257	0.00257	CcSEcCtD
